These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 27302163)

  • 1. PTK6 Inhibition Suppresses Metastases of Triple-Negative Breast Cancer via SNAIL-Dependent E-Cadherin Regulation.
    Ito K; Park SH; Nayak A; Byerly JH; Irie HY
    Cancer Res; 2016 Aug; 76(15):4406-17. PubMed ID: 27302163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative Breast Cancer Metastases.
    Ito K; Harada I; Martinez C; Sato K; Lee E; Port E; Byerly JH; Nayak A; Tripathi E; Zhu J; Irie HY
    Cancer Res Commun; 2024 Mar; 4(3):946-957. PubMed ID: 38457262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taxol Induces Brk-dependent Prosurvival Phenotypes in TNBC Cells through an AhR/GR/HIF-driven Signaling Axis.
    Regan Anderson TM; Ma S; Perez Kerkvliet C; Peng Y; Helle TM; Krutilina RI; Raj GV; Cidlowski JA; Ostrander JH; Schwertfeger KL; Seagroves TN; Lange CA
    Mol Cancer Res; 2018 Nov; 16(11):1761-1772. PubMed ID: 29991529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIF-1α-independent hypoxia-induced rapid PTK6 stabilization is associated with increased motility and invasion.
    Pires IM; Blokland NJ; Broos AW; Poujade FA; Senra JM; Eccles SA; Span PN; Harvey AJ; Hammond EM
    Cancer Biol Ther; 2014 Oct; 15(10):1350-7. PubMed ID: 25019382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of PTK6 expression in triple negative breast cancer.
    Chen Y; Qu W; Tu J; Yang L; Gui X
    BMC Womens Health; 2023 Nov; 23(1):575. PubMed ID: 37932734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein tyrosine kinase 6 signaling in prostate cancer.
    Alwanian WM; Tyner AL
    Am J Clin Exp Urol; 2020; 8(1):1-8. PubMed ID: 32211448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting BRK-Positive Breast Cancers with Small-Molecule Kinase Inhibitors.
    Jiang J; Gui F; He Z; Li L; Li Y; Li S; Wu X; Deng Z; Sun X; Huang X; Huang W; Han S; Zhang T; Wang Z; Jiao B; Song S; Wang H; Chen L; Zhou D; Liu Q; Ren R; Zhang J; Deng X
    Cancer Res; 2017 Jan; 77(1):175-186. PubMed ID: 27758886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells.
    Ito K; Park SH; Katsyv I; Zhang W; De Angelis C; Schiff R; Irie HY
    NPJ Breast Cancer; 2017; 3():45. PubMed ID: 29167821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer.
    Orso F; Quirico L; Virga F; Penna E; Dettori D; Cimino D; Coppo R; Grassi E; Elia AR; Brusa D; Deaglio S; Brizzi MF; Stadler MB; Provero P; Caselle M; Taverna D
    Cancer Res; 2016 Sep; 76(17):5151-62. PubMed ID: 27328731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collapsin response mediator protein-1 (CRMP1) acts as an invasion and metastasis suppressor of prostate cancer via its suppression of epithelial-mesenchymal transition and remodeling of actin cytoskeleton organization.
    Cai G; Wu D; Wang Z; Xu Z; Wong KB; Ng CF; Chan FL; Yu S
    Oncogene; 2017 Jan; 36(4):546-558. PubMed ID: 27321179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BIM-EL localization: The key to understanding anoikis resistance in inflammatory breast cancer cells.
    Buchheit CL; Schafer ZT
    Mol Cell Oncol; 2016 Jan; 3(1):e1011474. PubMed ID: 27308529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-crystal structures of PTK6: With Dasatinib at 2.24 Å, with novel imidazo[1,2-a]pyrazin-8-amine derivative inhibitor at 1.70 Å resolution.
    Thakur MK; Birudukota S; Swaminathan S; Battula SK; Vadivelu S; Tyagi R; Gosu R
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1289-1295. PubMed ID: 27993680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The associated pyrazolopyrimidines PP1 and PP2 inhibit protein tyrosine kinase 6 activity and suppress breast cancer cell proliferation.
    Shim HJ; Kim HI; Lee ST
    Oncol Lett; 2017 Mar; 13(3):1463-1469. PubMed ID: 28454278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of PTK6 predicts poor prognosis in bladder cancer patients.
    Xu XL; Ye YL; Wu ZM; He QM; Tan L; Xiao KH; Wu RY; Yu Y; Mai J; Li ZL; Peng XD; Huang Y; Li X; Zhang HL; Zhu XF; Qin ZK
    J Cancer; 2017; 8(17):3464-3473. PubMed ID: 29151930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRK phosphorylates SMAD4 for proteasomal degradation and inhibits tumor suppressor FRK to control SNAIL, SLUG, and metastatic potential.
    Miah S; Banks CAS; Ogunbolude Y; Bagu ET; Berg JM; Saraf A; Tettey TT; Hattem G; Dayebgadoh G; Kempf CG; Sardiu M; Napper S; Florens L; Lukong KE; Washburn MP
    Sci Adv; 2019 Oct; 5(10):eaaw3113. PubMed ID: 31681835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer.
    Wozniak DJ; Kajdacsy-Balla A; Macias V; Ball-Kell S; Zenner ML; Bie W; Tyner AL
    Nat Commun; 2017 Nov; 8(1):1508. PubMed ID: 29142193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRKCQ inhibition enhances chemosensitivity of triple-negative breast cancer by regulating Bim.
    Byerly JH; Port ER; Irie HY
    Breast Cancer Res; 2020 Jun; 22(1):72. PubMed ID: 32600444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of protein kinase D inhibitor CRT0066101 on the cell migration of salivary adenoid cystic carcinoma.
    Chen J; Die L; Chen H; Zhang P
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2022 May; 40(3):320-327. PubMed ID: 38597014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTK6: An emerging biomarker for prognosis and immunotherapeutic response in clear cell renal carcinoma (KIRC).
    Lin L; Gong S; Deng C; Zhang G; Wu J
    Heliyon; 2024 Apr; 10(7):e29001. PubMed ID: 38596018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of immune-associated biomarker for predicting lung adenocarcinoma: bioinformatics analysis and experiment verification of PTK6.
    Xiong RH; Yang SQ; Li JW; Shen XK; Jin LM; Chen CY; Yue YT; Yu ZC; Sun QY; Jiang W; Jiang MZ; Wang XY; Song SX; Cao D; Ye HL; Zhao LR; Huang LP; Bu L
    Discov Oncol; 2024 Apr; 15(1):102. PubMed ID: 38573548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.